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Hepatitis C virus (HCV) is the major causative agent of blood-borne non-A non-B hepatitis. The persistence of HCV infection
is believed to reflect escape from the host immunosurveillance system by mutations in hypervariable region 1 (HVR1) of the
envelope protein 2 (E2). Two envelope proteins of HCV, E1 and E2, have been reported to form a heteromeric complex but
the exact organization of the viral envelope proteins remains uncertain. We examined the interaction of E1 and E2 by far-
Western blotting using the bacterial recombinant proteins and also by pull-down assay using mammalian expressed proteins.
The major E1-interacting site of E2 was mapped within the N-terminal part of E2 (NCD1) (aa 415 to 500 of the polyprotein).
Both HVR1 and HVR2, located at the N-terminal part of E2, were dispensable for the interaction. Although several discontinuous
regions within NCD1 seemed to contribute to the strong binding to E1, the highly conserved amino acid sequences flanking
HVR2 had the most significant effect. The amino acid residues ‘‘WHY’’ from 489 to 491 of E2 played an especially crucial
role since the constructs with the internal deletion or substitution of the residues showed severely impaired E1-binding. The
N-terminal part of E1 is important for the E2-binding as determined by far-Western blotting using the mammalian- and
bacterial-expressed E2 proteins as probes. The mammalian-expressed, glycosylated forms of the E1 and E2 proteins exhibited
E1–E2 binding activities similar to those of the bacterial-expressed, nonglycosylated forms in pull-down assays, suggesting
that glycosylation is not prerequisite for the heteromeric complex formation of E1 and E2. q 1997 Academic Press
INTRODUCTION Viral envelope proteins play roles in several aspects
of the viral life cycle such as receptor binding, penetra-
Hepatitis C Virus (HCV) is a small enveloped virus that tion of host cells, and virus morphogenesis at budding.
is believed to be the major causative agent of non-A non- Enveloped viruses contain one or more types of mem-
B hepatitis throughout the world (Kuo et al., 1989). The brane proteins that often constitute a higher order oligo-
molecular cloning of HCV revealed that its genome con- mer. Expression studies using recombinant HCV cDNA
tains a positive strand RNA of about 9.5 kb that encodes templates have demonstrated hetero-oligomer formation
a polyprotein of 3010–3033 amino acid residues (Choo between the E1 and the E2 proteins detected by immuno-
et al., 1989; Houghton et al., 1991). HCV has been classi- logical means (Grakoui et al., 1993; Lanford et al., 1993;
fied as a member of the family Flaviviridae because of Ralston et al., 1993; Dubuisson et al., 1994; Matsuura et
its similarity in genomic organization to flavivirus and al., 1994; Selby et al., 1994). Precise understanding of
pestivirus. The structural region of HCV is located at the virus structure may be possible through X-ray crystallog-
5*-terminal part of the genome and encodes the core, the raphy; the structure of the envelope glycoprotein E of tick-
envelope protein E1, and the second envelope protein borne encephalitis virus (TBE), belonging to the flavivirus,
E2 (Hijikata et al., 1991a; Miller and Purcell, 1990). The has been reported (Rey et al., 1995). However, the model
hypervariable regions (HVR), HVR1 and HVR2, have been of the TBE E protein could not be applied directly to
identified at the N-terminal part of E2 (Hijikata et al., understanding the structure of HCV envelope proteins
1991b; Ogata et al., 1991; Okamoto et al., 1992a; Weiner because the TBE E protein has only limited homology to
et al., 1991). Escape from the host immunosurveillance HCV E1 and E2.
by means of mutations in HVR1 might be involved in the Here we report the E1–E2 binding by far-Western blot-
mechanism of persistent infection by HCV, which results ting and pull-down assay mainly using bacterial-ex-
in chronic hepatitis and eventually hepatocellular carci- pressed recombinant proteins. The major contribution to
noma (Okada et al., 1992; Weiner et al., 1992; Kato et al., the E1-binding of E2 was mapped within the region in
1993; Kojima et al., 1994). the vicinity of HVR2, and the ‘‘WHY’’ sequence within the
region played a crucial role in the E1–E2 association.
Neither HVR1 nor HVR2 of E2 were necessary for the1 To whom correspondence and reprint requests should be
interaction. We also demonstrated by far-Western blot-addressed. Fax: 81-762-23-2443. E-mail: semuraka@kenroku.ipc.
kanazawa-u.ac.jp. ting using bacterial, nonglycosylated, or mammalian gly-
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TABLE 1 PCR to construct the substitution mutants, one to amplify
the upstream and the other to amplify the downstreamPrimers Used to Construct Deleted Derivatives of E1 and E2
part of the substituted sequence, after ligation through
Expression the artificial restriction site included in the primer’s se-
vector Primer pair Enzyme quences. The oligonucleotides used to construct the
sRPY mutant were NCD1/ sense (see Table 1) and 5*-E1 GACGAATTCCATGTATGAAGTGCGCAACGTG EcoRI/BglII
ATGAGATCTCCCGTCAACGCCGGCA GCGCATGCTCCGAGCTGCGAGACTCAGC-3* (antisense)
E1t This plasmid was generated by digestion of EcoRI/BamHI for the upstream fragment, and 5*-GAGCATGCGGCTGC-
the PCR fragment of E1 with EcoRI and
CTGCTGGCACTACG-3* (sense) and NCD1/antisenseBamHI (located at nt 1341 of JK1)
E2t GCGAATTCCATGACTACCTACGTGTCAGTGGGG EcoRI/BamHI (Table 1) for the downstream region. The PCR products of
GCGGATCCCTCTGACCTATCCCTGTCCTC the upstream and the downstream regions were digested
E2t-t1 GCGAATTCCATGACTACCTACGTGTCAGTGGGG EcoRI/BglII
with EcoRI/SphI and SphI/BglII, respectively, ligated, andATGAGATCTCAACGCGGGCACCATACC
E2t-t2 GCGAATTCCATGCAGGTGTGCGGTCCAGTG EcoRI/BamHI then inserted into pGenK1 digested with EcoRI and
GCGGATCCCGAGCCGCACTTGGTGTAAGT BamHI. The oligonucleotides used to construct the sWHY
E2t-t3 GCGAATTCCATGGGGCCTTGGTTGACACCTA EcoRI/BamHI
mutant were NCD1/sense and 5*-GCGTCGACGCCGCG-GCGGATCCCTCTGACCTATCCCTGTCCTC
ND1 GCGAATTCCATGACTACCTACGTGTCAGTGGGG EcoRII/BamHI CAGTAAGGCCTTTGGTC-3* (antisense) for the upstream
GCGGATCCTCGAGGGGACGACAGCTAGCCATG and 5*-GCGTCGACACCTCAACCGTGTGGTATC-3* (sense),
ND2 GCGAATTCCATGACTACCTACGTGTCAGTGGGG EcoRI/BamHI
and NCD1/antisense for the downstream region. TheGCGGATCCTCTGAGCATCCAGACGAGTTGAA
NCD1 GCGAATTCCATGAACACCAACGGCAGTTGGCAC EcoRI/BglII PCR products of the upstream and downstream regions
ATGAGATCTCAACGCGGGCACCATACC were digested with EcoRI/SalI and SalI/BglII, respec-
NCD2 GCGAATTCCATGCTGTTCTACGTAAAGAAGTTCA EcoRI/BglII
tively, ligated, and inserted into pGENK1. The resultingATGAGATCTCAACGCGGGCACCATACC
NCD3 GCGAATTCCATGGCTAGCTGTCGTCCC EcoRI/BglII substitutions are shown in Fig. 6A. We constructed inter-
ATGAGATCTCAACGCGGGCACCATACC nal deletion mutants by means of a similar strategy.
NCD4 CGGAATTCCATGAGGCCTTACTGCTGGCACTAC EcoRI/BglII
The PCR fragments of the upstream and downstreamATGAGATCTCAACGCGGGCACCATACC
NCD1N NCD1 was digested with NheI and filling in regions were ligated through the artificial SmaI site in-
and ligation was done to make this cluded in the primer’s sequence or the StuI site of the
construct
original JK1 sequence, resulting in one or two artificial
amino acids at the junction points of each constructNote. PCR fragments amplified with each primer set were digested
with the indicated enzymes and inserted into the pGENK1 vector di- (Table 2, Fig. 5).
gested with EcoRI/BamHI. Artificial sequences are in italic. Underlines The His-tagged expression vector, pLHis, was derived
indicate the enzyme sites. from 6HisT–pET11d (Novagen) by replacing the po-
lycloning site with the modified polylinker as shown in
Fig. 8. The same PCR products, used to construct E1tcosylated E2 protein as probe that the E2-binding region
and E2t, were digested with EcoRI and BamHI and in-was located within the N-terminal part of E1.
serted into the EcoRI and BamHI sites of 6His–pET11d.
To construct a mammalian expression vector of E1,
MATERIALS AND METHODS gE1t–GST (the PCR product of HCV (724–1473) using 5*-
GCGAATTCATGGGGTACATTCCGCTCGTCGG-3* as thePlasmid construction
5* primer and the 3* primer of E1 (Table 1) was digested
with EcoRI and BamHI and inserted into the EcoRI andThe vector, pGENK1, was used to construct bacterial
expression plasmids of the E1 and E2 proteins. The vec- BamHI sites of mammalian expression vector pSGUTPL
(Murakami et al., 1994). The resulting plasmid pSGUTPL–tor was derived from pGEX-1N (Amrad Co. Ltd., Kew,
Victoria, Australia) by replacing the polycloning site with gE1t was digested with BamHI and ligated with the DNA
fragment of GST with the artificial BglII and BamHI sitethe modified polylinker as shown in Fig. 1. The resulting
glutathione-S-transferase (GST) fusion proteins of at the 5*- and 3*-terminus, respectively. A similar method
was applied to construct a mammalian expression plas-pGENK1 have an artificial phosphorylation site and can
be used for in vitro kination (Fig. 1) (Murakami et al., mid of E2 except that the BamHI and XhoI fragment of
HCV JK1 (1340–2269) and the PCR fragment of GST se-1994). Deletion mutants of E1 and E2 subgenomic re-
gions of the HCV-Jk1 clone (Honda et al., 1993) were quence with the artificial XhoI and BamHI site at the
5*- and 3*-terminus, respectively, were used to constructconstructed by means of PCR with the primer sets con-
sisting of a 5* primer with an EcoRI site and a 3* primer gE2t–GST. The internal deletion construct of gE2t–GST,
gE2t–GST/D, was constructed as follows. Two PCR frag-with a BamHI or a BglII site for cloning (Table 1). The
PCR products digested with EcoRI and BamHI or BglII ments of gE2t–GST using primer pairs T7 (sense primer
of upstream of pSGUTPL vector)/5*-GCGGATCCGTAGT-were inserted into the EcoRI and BamHI sites of the
expression vector. We designed two sets of primers for GCCAGCAGTAAGGCCT-3* (anti-sense) and 5*-GCCCC-
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TABLE 2
Primers Used for the Internal Deletion Constructs
Expression
vector Primers for the N-terminal fragment Primers for the C-terminal fragment Enzymes
GCGAATTCCATGAACACCAACGGCAGTTGGCAC GCGAATTCTCCCGGGCAAGGGTGGGGTCCCATC
NCD1-11 GAAGGCCTACCCGGGGTTGATGGACTCGTTGC ATGAGATCTCAACGCGGGCACCATACC EcoRI/SmaI SmaI/BglII
GCGAATTCCATGAACACCAACGGCAGTTGGCAC CGGAATTCCATGAGGCCTTACTGCTGGCACTAC
NCD1-12 GAAGGCCTACCCGGGGTTGATGGACTCGTTGC ATGAGATCTCAACGCGGGCACCATACC EcoRI/SmaI StuI/BglII
GCGAATTCCATGAACACCAACGGCAGTTGGCAC CGGAATTCCATGAGGCCTTACTGCTGGCACTAC
NCD1-12N GAAGGCCTACCCGGGGTTGATGGACTCGTTGC GCGGATCCGTAGTGCCAGCAGTAAGGCCT EcoRI/SmaI StuI/BamHI
GCGAATTCCATGAACACCAACGGCAGTTGGCAC GCCCCGGGCAACCGTGTGGTATCGTGCC
NCD1-12C GAAGGCCTACCCGGGGTTGATGGACTCGTTGC ATGAGATCTCAACGCGGGCACCATACC EcoRI/SmaI SmaI/BglII
GCGAATTCCATGAACACCAACGGCAGTTGGCAC GCGAATTCTCCCGGGCAAGGGTGGGGTCCCATC
NCD1A GCGGATCCCGGGACGACAGCTAGCCATGCGC ATGAGATCTCAACGCGGGCACCATACC EcoRI/SmaI SmaI/BglII
GCGAATTCCATGAACACCAACGGCAGTTGGCAC GCGAATTCTCCCGGGACCCATGCTGAGTCTCG
NCD1B GCGGATCCCGGGAGCGAACCTGTCAATGGGAC ATGAGATCTCAACGCGGGCACCATACC EcoRI/SmaI SmaI/BglII
NCD1C This plasmid was generated from NCD1B by digestion with SmaUI/StuI and ligation
GCGAATTCCATGAACACCAACGGCAGTTGGCAC GCCCCGGGCAACCGTGTGGTATCGTGCC
NCD1D GCGGATCCGTAGTGCCAGCAGTAAGGCCT ATGAGATCTCAACGCGGGCACCATACC EcoRI/StuI SmaI/BglII
Note. Each N-terminal or C-terminal fragment was generated by PCR using the primers indicated. After digestion of the fragments with the
indicated enzymes they were inserted into the pGENK1 vector, which was digested with EcoRI/BamHI. Some of the sequences generated during
cloning are shown in Fig. 5.
GGGCAACCGTGTGGTATCGTGCC-3* (sense)/SG3 (anti- Protein preparation and Western blotting
sense primer downstream of the pSGUTPL vector) were
Plasmids encoding the GST fusion protein of E1 ordigested with EcoRI/StuI and SmaI/XhoI, respectively,
and inserted into gE2t– GST digested with EcoRI/XhoI. E2 were transformed into Escherichia coli strain JM109.
Overnight cultures of each transformant were diluted 1:10The resulting deletion corresponds to residues 484–491
within HCV JK1. with new LB medium and cultured at 377 until the mid-
FIG. 1. Construction of HCV E1 and E2 expression plasmids. (A) The GST expression vector pGENK1. All the HCV subgenomic cDNA fragments
were inserted into the EcoRI and the BamHI site of pGENK1 and expressed as GST-fused proteins in E. coli. Underlined are thrombin cleavage
and kination sites for the in vitro labeling with (g-32P]ATP. (B) Hydrophobic profile of E1 and E2 proteins is shown under the HCV polyprotein
structure. The polyprotein structure is not drawn to scale. Expression constructs for E1 and E2 proteins are shown at the bottom. Numbers indicate
amino acid positions within the HCV polyprotein precursor (Honda et al., 1993).
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Far-Western blotting
32P-labeled GST fusion proteins were prepared as de-
scribed previously (William et al., 1992; Murakami et al.,
1994). Briefly, purified proteins using glutathione–Sepha-
rose were resuspended in 11 HMK buffer (20 mM Tris,
pH 7.5, 100 mM NaCl, 12 mM MgCl2) containing 1 U/ml of
the catalytic subunit of cAMP-dependent protein kinase
(Sigma Co. Ltd.), 1 mCi/ml [g-32P]ATP (10 mCi/ml; Amer-
sham International plc.), and 1 mM dithiothreitol (DTT)FIG. 2. The N-terminal part of E2 protein (E2t-t1) is important for
and the kinase reaction proceeded for 1 hr at 307. Far-the interaction with E1. (A) E1 and E2 constructs shown in Fig. 1
Western blotting proceeded as described (William et al.,were expressed in E. coli, partially purified, separated by SDS – 10%
PAGE, and stained with Coomassie brilliant blue dye. (B) Result of 1992; Murakami et al., 1994) with some modification. The
far-Western blots. The same amount of proteins shown in (A) were transferred membranes were blocked in H buffer (10 mM
transferred to a nitrocellulose membrane and probed with 32P-labeled Hepes, pH 7.6, 150 mM NaCl, 0.05% Tween 20, 0.03%E1t probe.
SDS) with 2% of BSA for 30 min. The binding reaction
proceeded at room temperature in H buffer containing
2% BSA and 10 mg/ml of purified GST protein. The 32P-log phase. The recombinant proteins were induced with
labeled GST-fused E1 protein was added at 1–2 1 1050.2 mM isopropyl-1-thio-b-D-galactoside (IPTG) for 2 hr.
cpm/ml. After a 1-hr incubation, the membranes wereAfter pelleting by standard procedures, the pellets were
washed with H buffer twice for 10 min, dried, and ex-washed once with phosphate-buffered saline (PBS) con-
posed to imaging plates (Fuji Co. Ltd.) or X-ray films (XAR-taining 0.5% Triton X-100 (PBST) and lysed on ice by mild
Omat, Kodak Co. Ltd.).sonication in a 1/10 culture volume of PBST. Sonicated
pellets were recovered by centrifugation at 3000 g for 10 Pull down of GST-fused proteins by His-tagged E1
min. The resultant pellet fractions containing most of the and E2
induced proteins were resuspended in SDS sample
Pull-down assay was carried out in H buffer containingbuffer (0.0625 M Tris, pH 6.8, 2% SDS, 10% glycerol, 5%
2% BSA. Briefly GST-fused proteins labeled with [g-32P]-2-mercaptoethanol), heated at 1007 for 5 min, fractionated
ATP were added to the Probond resin prebound by His-by 12.5% SDS–PAGE, then electrically transferred to ni-
tagged E1 or E2. After overnight binding at room tempera-trocellulose membranes (Pharmacia LKB Biotechnology
ture the resins were washed two times with H buffer andInc. Ltd. Co.) in 192 mM glycine, 25 mM Tris, and 20%
three times with H buffer containing 0.5% SDS. Retainedmethanol. Western blotting with anti-HCV-positive human
proteins were eluted by adding SDS sample buffer,serum (the major epitope of E2 was located within
heated at 1007 for 5 min, and fractionated by 12.5% SDS–NCD1N, see Fig. 4; 1:1000 dilution) and with rabbit anti-
GST IgG (1:5000 dilution) was performed as described
(Murakami et al., 1994). The bands were visualized by
using an ECL reagent kit (Amersham Corp.).
Plasmids encoding His-tagged E1 or E2 were trans-
formed into E. coli strain BL21 and recombinant proteins
were induced with 1 mM IPTG for 3 h at 307. Recombinant
proteins were purified using Probond Metal Binding resin
(Ni2/ charged Sepharose resin, Invitrogen) according to
the manufacturer’s procedures for denaturing purifica-
tion. Purified proteins were rebound to the Probond resin
and used for pull down of the GST-fused E1 or E2 pro-
teins. To purify the proteins expressed in HepG2 cells,
transfected cells were lysed in lysis buffer (50 mM Tris,
pH 7.5, 150 mM NaCl, 1% Triton) and the supernatant
was recovered by centrifugation at 12,000 g for 10 min.
The proteins were purified using glutathione–Sepharose
4B (Pharmacia LKB Co. Ltd.). To inhibit glycosylation of
FIG. 3. HVR1 of E2 did not contribute to the association with E1. (A)the expressed proteins, tunicamycin (Wako Pure Chem.
The E2t-t1 region was divided into two parts, one of which contained
Co. Ltd., 1 mg/ml at final concentration) was added to HVR1. (B) Expressed proteins were separated by SDS–10% PAGE and
the medium of the transfected HepG2 cells at the indi- stained with Coomassie brilliant blue dye. (C) Far-Western blots probed
with 32P-labeled E1.cated time (Fig. 7A) before harvest.
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FIG. 4. The E1-binding activity is not confined within a small continuous region of E2. (A) Stepwise and internal deletion mutants were constructed
to determine essential E1-binding regions within the NCD1, the major contributing region for the E1-binding (Fig. 3). (B) Partially purified proteins
were separated by SDS–10% PAGE. (C) Result of a far-Western blot probed with 32P-labeled E1.
PAGE. After drying, the gels were exposed to imaging (aa 470–479) (Hijikata et al., 1991; Ogata et al., 1991;
Okamoto et al., 1992a; Weiner et al., 1991). Since the E1-plates (Fuji Co. Ltd.) or X-ray films (XAR-Omat, Kodak Co.
Ltd.) and bound fractions were analyzed quantitatively binding activity was located within the N-terminal part of
E2 (E2t-t1) including both HVRs, we first examinedwith a Fujix Bioimaging analyzer BAS-1000 (Fuji Co. Ltd.).
For competition, tE2 purified with glutathione–Sepharose whether HVR1 is important for the E1–E2 association.
Several mutants truncated either at the N-terminal or atwas used. Relative concentration of tE2, compared to
labeled protein, was checked by Western blotting using the C-terminal portion of E2t-t1 were constructed and
examined the interaction by far-Western blotting. Asanti-GST antibody (data not shown).
shown in Fig. 3C, the truncated protein, NCD1 lacking
HVR1, interacted with the E1 probe even more stronglyRESULTS
than the original E2t-t1 protein (compare lanes 2 and 5).
The N-terminal part of E2 but not HVR1 contributes
In contrast, the constructs truncated at the C-terminal
to the E1–E2 association
region of E2t-t1, ND1 and ND2, had markedly decreased
binding to the E1 probe, although these proteins containWe investigated the nature of the interaction between
E1 and E2 protein by far-Western blotting, which can di- HVR1. These results demonstrated that HVR1 is dispens-
able and that the C-terminal part of E2t-t1 is importantrectly detect protein–protein interaction. Because the full-
length constructs of both E1 and E2 did not give detect- for the interaction with E1.
able levels of protein expression in GST-fused forms in
E. coli, both the E1 and the E2 used in this study, E1t The E1-binding activity of E2 is not confined within a
and E2t, respectively, were truncated at the C-terminal continuous short region
transmembrane portions (Yan et al., 1994) (Fig. 1).
The 32P-labeled E1t probe bound E2t as shown in Fig. We constructed several truncated mutants of the C-
terminal portion of E2t-t1 to delineate the E1-binding re-2. To delineate the E1-binding region, E2t was tentatively
divided into three parts, E2t-t1, E2t-t2, and E2t-t3 (Fig. gion (Fig. 4A). NCD1 (415–500) bound the E1 probe but
further truncation of the N-terminal part of NCD1 weak-1B). The protein band of E2t-t1 was clearly detected by
the E1 probe, while both E2t-t2 and E2t-t3 were hardly ened the binding by extent of deletion, although the short-
est construct, NCD4 (484–500), retained binding abilitydetected, suggesting the importance of the N-terminal
portion of E2 for this interaction (Fig. 2, compare lanes (Fig. 4C, lanes 3 to 6). In contrast, the construct truncated
at the C-terminal region of NCD1, NCD-1N, bound E1 little3, 4, and 5).
HCV E2 protein contains the hypervariable regions, if at all (Fig. 4C, lane 8). Thus the most C-terminal end of
NCD1 may be crucial for the E1-binding. Next we exam-HVR1 at the very N-terminal part (aa 384–415) and HVR2
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HCV isolates. Residues should be highly conserved if
they are important in viral structure or function. Within the
E1-binding region of E2 (460–500), there are two amino
acid sequences, boxes X and Y, flanking HVR2, that are
highly conserved among various HCV isolates (Okamoto
et al., 1992b) (Fig. 5A). We examined whether these con-
served sequences contribute to the E1–E2 association
by introducing scanning internal deletions around these
sequences (Fig. 5A). The NCD1D construct lacking the
box Y sequence (484–491) lost the E1-binding activity
almost completely (Fig. 5C, lane 6). In contrast, not much
effect in the E1-binding activity was observed by the inter-
nal deletion encompassing HVR2, and by those, NCD1A
and NCD1B, deleting a rather nonconserved sequence
and box X, respectively (Fig. 5C, lane 7 and also Fig. 6C,
lane 4). These results suggest that box Y (484–491) is
indispensable for the E1-binding. To confirm the critical
role of box Y (484–491), two substitution mutants covering
a part of the region (Fig. 6A) were constructed. The sWHY
mutant showed markedly impaired E1-binding but the
sRPY exhibited a binding ability similar to that of NCD1
(Fig. 6C, compare lane 3 with lanes 5 and 6). These find-
ings indicate that the WHY sequence in box Y has a
critical role in the E2-binding to E1.
FIG. 5. Some conserved sequences around HVR2 are crucial for the
E1-binding activity. (A) The amino acid sequences of E2t-t1 derived from
HCV JK1 (8) are shown. The overbars indicate the locations of HVR1 and Glycosylated E2 protein expressed in HepG2 cells
HVR2. Boxes X and Y, flanking HVR2, contain the residues that are highly binds the N-terminal part of E1
conserved among diverse HCV isolates. The lower part shows scanning
deletion constructs including these conserved residues. The underlines
We also performed far-Western blotting using E2t ex-indicate the deleted residues in each construct, and the artificial residues
pressed in E. coli (Fig. 1) as the probe to detect thegenerated during construction of these mutants are included in Boxes A
to D. Numbers indicate the positions of residues within the HCV polypro- interaction with E1. As shown in Fig. 7B, the E2t probe
tein. (B) The proteins were expressed in E. coli and fractionated by SDS– binds the N-terminal part of E1 (E1t-t1).
10% PAGE. (C) Far-Western blot probed with E1.
Since E1 and E2 are glycosylated in mammalian cells,
we addressed the effect of glycosylation on the E1–E2
ined whether the E1-binding requires a continuous region interaction. HepG2 cells were transfected with gE1t–
in NCD1, by introducing internal deletions (Fig. 4A). As GST or gE2t–GST, which encodes E1t or E2t fused with
shown in Fig. 4C, the construct, NCD1-I1, having fused GST at the C-terminus. The expressed proteins were
N-terminal (415–434) and C-terminal (467–500) regions, purified by glutathione–Sepharose and could be de-
bound E1 with an activity as high as that of NCD1 (com- tected by anti-GST antibody (Fig. 7A). The gE2t–GST was
pare lanes 3 and 9). The N- and the C-terminal regions of expressed well but the gE1t–GST was poorly expressed
NCD1-I1 exhibited no or weak E1-binding activity, respec- under the conditions we applied. To determine whether
tively. In contrast to NCD1-I1, NCD1-I2, with the N-terminal these proteins are expressed as the glycosylated forms,
part (415–434) fused to a shorter C-terminal portion (484– cells were grown in the presence of tunicamycin, an
500) of NCD1, did not exhibit stronger E1-binding than inhibitor of N-linked glycosylation. For both proteins,
that of the C-terminus (484–500) alone (Fig. 4C, lanes 5 faster migrating bands were recovered after tunicamycin
and 10). These results suggest that several discontinuous treatment, indicating that they were expressed as the
regions contribute to the E1-binding activity of NCD1 and glycosylated forms. The purified, glycosylated gE2t–GST
that the N-terminal portion (415–434) and the region span- was labeled in vitro and used as the probe for far-West-
ning 467 to 484 may play a helping role to increase the ern blotting to detect E1-binding. The relative specificity
core E1-binding activity of the C-terminal part (484–500). and the intensity of the bands detected by the gE2t–GST
A conserved sequence in the vicinity of HVR2, but not probe were similar to those by the bacterial, nonglycosyl-
HVR2, is crucial for the E1-binding activity ated E2t probe. The results indicate that both glycosyl-
ated and nonglycosylated E2 proteins can bind E1Even outside the hypervariable regions, there are many
amino acid substitutions in the E2 protein among different through the N-terminal part of E1.
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FIG. 6. Effects of substitution mutations of Box Y (Fig. 5) on the E1-binding activity. (A) Two substitution mutants of NCD1 (sRPY and sWHY) were
constructed. Changed amino acids are shown in the boxes. (B) Western blotting of GST-fused derivatives of E2 using anti-GST antibody or anti-
HCV-positive human serum. The result indicated that a similar amount of proteins was transferred to the membrane. (C) Far-Western blotting of
the fractionated proteins shown in (B) detected by the E1 probe.
pressed in E. coli, were purified using metal-binding resinPull-down assay using His-tagged E1 and E2
(Fig. 8A). Mammalian- or bacterial-expressed, purified,
The effect of glycosylation on the E1–E2 interaction GST-fused proteins labeled by in vitro kination using [g-
was examined by another method, pull-down assay. His- 32P]ATP were mixed with the resins prebound by His-E1t
or His-E2t and subjected to pull-down assay. The His-E1t and His-E2t, N-terminal His-tagged proteins ex-
FIG. 7. Both nonglycosylated and glycosylated E2 bind the N-terminal part of E1. (A) Proteins expressed in HepG2 cells and purified by glutathione–
Sepharose were detected by Western blotting using anti-GST antibody. (Top) The constructs used to express the glycosylated E1 and E2 in HepG2
cells. The putative processing sites (#, nucleotide position) within the HCV polyprotein precursor (Honda et al., 1993) are shown. TM15 indicates
tunicamycin treatment of transfected HepG2 cells for 15 hr before harvest. The amount of GST (lanes 3, 4) and gE2t–GST (lanes 5, 6) was from 2–
3 1 105 transfected cells and gE1t–GST (lanes 1, 2) was from 9–10 1 106 transfected cells. (B) (Top) the deletion constructs of E1t expressed in
E. coli. Numbers indicate the amino acid positions within the polyprotein. (Bottom left) Coomassie staining of proteins separated by SDS–10%
PAGE is shown. (Bottom middle and right) Results of far-Western blot of the truncated E1 proteins probed with 32P-labeled tE2 (Fig. 1, nonglycosylated)
(middle) and 32P-labeled gE2t– GST (Fig. 7A, glycosylated) (right).
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FIG. 8. Pull-down assay of E1 and E2 proteins. (A) (Left) The bacterial expression vectors of His-E1t and His-E2t, derived from pLHis. (Right)
Coomassie staining of His-E1t and His-E2t, after rebinding of purified proteins to Ni2/ resin, boiled in SDS sample buffer and separated by SDS–
12.5% PAGE. (B) Glycosylated as well as nonglycosylated E1 and E2 proteins exhibited the heteromeric-binding activity detected by pull-down
assay using the His-E2t-bound (lanes 1– 3) and His-E1t-bound (lanes 4 –7) resin. Examined 32P-labeled proteins are GST, gE1t– GST, and E1t
(lanes 1 –3) and GST, gE2t– GST, gE2t–GST (from tunicamycin-treated HepG2 cells), and E2t (lanes 4– 7), respectively. After binding, each protein
was separated directly by SDS – 10% PAGE, dried, and subjected to fluorography. ‘‘I’’ and ‘‘U’’ indicate 10% of input and unbound protein, respectively,
except 2.5% of input in lane 31. ‘‘B’’ indicates total amount of bound protein. The labeled input proteins of GST and gE2t– GST are from the 1– 2
1 105 transfected HepG2 cells and that of gE1t–GST is from the 8 –9 1 106 transfected cells. (C) Pull-down assay using the His-E1t-bound resin.
Examined 32P-labeled proteins are gE2t– GST (lane 1) and gE2t –GST/D (truncated mutation of ‘‘Box Y’’ (Fig. 5)) (lane 2). ‘‘I’’ and ‘‘U’’ indicate 10%
of input and unbound protein, respectively. ‘‘B’’ indicates total amount of bound protein. For competition assay 50001 excess amount of purified
tE2 was added.
E2t prebound resin selectively pulled down glycosylated The crucial role of ‘‘Box Y’’ in the E1 binding of E2
(Fig. 5) was also examined by pull-down assay, usinggE1t–GST (Fig. 8B, band b) as well as bacterial-ex-
pressed E1t (Fig. 8B, band d), but not GST or degradated mammalian-expressed E2 proteins with or without Box
Y, gE2t – GST, and gE2t – GST/D, respectively. Deletionproducts that have the GST portion in the bacterial- or
mammalian-expressed fractions (Fig. 8B, bands c and e). of Box Y severely impaired E1-binding activity com-
pared to that of wild type, gE2t – GST, in pull-downSimilarly the His-E1t prebound resin pulled down the
glycosylated gE2t–GST as well as the nonglycosylated assay using the His-E1t resin (Fig. 8C and summarized
in Table 4). Additionally, the E1-binding of gE2t – GSTform E2t (Fig. 8B, bands g, h, and i). We observed that the
faster migrating form of gE2t–GST from the tunicamycin- was efficiently competed out by excess amount of the
bacterial-expressed tE2; however, the weak residualtreated HepG2 cells was more efficiently pulled down
than the intact gE2t–GST or the E2t expressed in E. E1-binding of gE2t – GST/D was unaffected by excess
amount of the competitor, tE2. These results demon-coli (see Discussion). The results of the pull-down assay
suggest that the glycosylation of E1 and E2 does not strate the importance of Box Y of mammalian-ex-
pressed as well as bacterial-expressed E2 proteins tohave much effect on the E1–E2 binding (summarized in
Table 3). E1 binding (Figs. 5 and 8).
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TABLE 3
Relative Recovery of Proteins in Pull Down Experiments Shown in Fig. 8B
Labeled proteins Recovery (% of input)
Proteins prebound
Lanes to the metal resin Source Proteins Unbound Bound
1 His-E2t HepG2 GST (a) 68 1
2 His-E2t HepG2 gE1t-GST (b) 48 7.1
(c) 59 1
3 His-E25 E. coli E1t (d) 47 11.6
(e) 73 1
4 His-E1t HepG2 GST (f) 53 1
5 His-E1t HepG2 gE2t-GST (g) 35 11.4
6 His-E1t HepG2 (tunicamycin) gE2t-GST (g) 34 10.2
(h) 21 20.6
7 His-E1t E. coli E2t (i) 54 5.8
(j) 53 1.4
Note. The data were analyzed with a Fujix Bioimaging analyzer BAS-1000 (Fuji Co. Ltd.). The numbers indicate the recovery (%) of total unbound
and bound compared to the input.
and E2. In accordance with our results Matsuura et al.DISCUSSION
(1994) reported that the mutants lacking both the inter-
We demonstrated that the E1 protein of HCV can bind nal and the C-terminal hydrophobic regions of E1 and
the E2 protein in vitro by far-Western blotting and that E2 could be coimmunoprecipitated in the baculovirus
the N-terminal part of E2 spanning amino acid residues expression system. These results may not eliminate
415–500 greatly contributes to the E1-binding. We found the possibility that the transmembrane domains of E1
that the amino acid residues 484–491, a highly con- and E2 interact with each other, apart from the extracel-
served sequence flanking HVR2, have an indispensable lular portion, as suggested previously (Selby et al.,
role in E1-binding. The crucial role of the sequence was 1994).
supported by pull-down assay using mammalian-ex- The presence of the hypervariable regions, especially
pressed E2 protein. We also showed that the E2-binding HVR1, in E2 causes HCV to escape from host immune
region within E1 was localized to the N-terminal part of surveillance (Kato et al., 1993; Kojima et al., 1994). We
E1 through in vitro binding assays. Glycosylation may not investigated whether these HVRs were involved in the
have the critical role on the heteromeric interaction since hetero complex formation. Our results demonstrated that
neither HVR1 nor HVR2 were necessary for the E1– E2both bacterial- and mammalian-expressed E1 and E2
behaved similarly in our experimental system. interaction. The region crucial for the E1-binding defined
in this study includes the highly conserved amino acidOur results indicated that E1 and E2 could interact
with each other through the extracellular portion of E1 sequence flanking HVR2. Our findings may support the
TABLE 4
Relative Recovery of Proteins in Pull Down Experiments Shown in Fig. 8C
Labeled proteins Recovery (% of input)
Proteins prebound
Lanes to the metal resin Source Proteins Competitor Unbound Bound
1 His-E1t HepG2 gE25-GST 33 9.4
tE2 52 1
2 His-E1t HepG2 gE2t-GST/D 45 2.1
tE2 51 1.5
Note. The data were analyzed with a Fujix Bioimaging analyzer BAS-1000 (Fuji Co. Ltd.). The numbers indicate the recovery (%) of total unbound
and bound compared to the input.
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C virus genome by in vitro processing. Proc. Natl. Acad. Sci. USAnotion that E1 and E2 may interact through the highly
88, 5547–5551.conserved sequences.
Hijikata, M., Kato, N., Yoshizawa, Y., Nakagawa, M., Ohkoshi, S., and
HCV envelope proteins are modified by glycosylation Shimotohno, K. (1991b). Hypervariable regions in the putative glyco-
in nature and carbohydrate may play a role in subunit protein of hepatitis C virus. Biochem. Biophys. Res. Commun. 175,
220–228.assembly (Doms et al., 1993; Fenonillet et al., 1994). Our
Honda, M., Kaneko, S., Unoura, M., Kobayashi, K., and Murakami, S.results suggest that glycosylation of E1 and E2 might be
(1993). Sequence analysis of putative structural regions of hepatitisnot critical for the heteromeric interaction. In the far-
C virus isolated from 5 Japanese patients with hepatocellular carci-
Western blotting, relative specificity and the efficiency noma. Arch. Virol. 128, 163–169.
of the E1–E2 bindings detected by the glycosylated E2 Houghton, M., Weiner, A., Han, J., Kuo, G., and Choo, Q.-L. (1991).
Molecular biology of the hepatitis C viruses: Implications for diagno-probes were similar to those detected by the bacterial
sis, development and control of viral disease. Hepatology 14, 381–expressed ones. In the pull-down assays, mammalian-
388.expressed, glycosylated forms of the E1 and E2 proteins
Kato, N., Sekiya, H., Ootsuyama, Y., Nakazawa, T., Hijikata, M., Ohkoshi,
exhibited E1–E2 binding activities similar to those of the S., and Shimotohno, K. (1993). Humoral Immune response to Hyper-
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